STILNOX
The "STILNOX" trademark, serial number 78826319 , was filed on 1st of March 2006 with a mark drawing code of 4000 and its transaction date is 78826319. The attorney assigned is Susan Upton Douglass, attorney docket number SYN 0508899. Since 8th of March 2012, the document can be found in the L80 law office in the publication and issue section. The employee responsible is CARL III, FRED and the date it was published for opposition on 11/13/2007. The date when we last checked the status of this trademark was 01/29/2008.
The "STILNOX" trademark, serial number 85824235 , was filed on 16th of January 2013 with a mark drawing code of 4000 and its transaction date is 85824235. The attorney assigned is G. MATHEW LOMBARD, attorney docket number 101.0611. Since 13th of January 2014, the document can be found in the N10 law office in the publication and issue section. The employee responsible is BULLOFF, TOBY ELLEN and the date it was published for opposition on 07/23/2013. The status of this trademark was checked last on 09/17/2013.
Prior registrations: 3376002
The corresponded responsible for this trademark is G. MATHEW LOMBARD, located at LOMBARD & GELIEBTER LLP, 1115 BROADWAY FL 12, NEW YORK, NY 10010-3452.The state or country where the trademark was organized is by Sanofi. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at 54 Rue La Boétie, Paris, zip 75008.Other trademarks by this applicant: CEPIA, SUREHOLD, SANOFI.
GOODS AND/OR SERVICES | |
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
---|---|
U.S. Class | 052 - Detergents and Soaps |
Class Status | 6 - Active |
Status Date | 01/22/2013 |
Primary Code | 005 |
Goods codes | |
GS0051 | Pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the treatment of sleep disorders, diseases and conditions |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
09/17/2013 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | E | NOAM | |
07/23/2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | E | NPUB - NOTICE OF PUBLICATION | |
07/23/2013 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
07/03/2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | E | NONP | |
06/14/2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
06/13/2013 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
05/28/2013 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
05/23/2013 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
05/22/2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
05/22/2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
05/06/2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
05/06/2013 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
05/06/2013 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
04/30/2013 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
01/22/2013 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
01/19/2013 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.